Mahefa Miaraka FY2017 Quarter 2 Report I
Total Page:16
File Type:pdf, Size:1020Kb
Community Capacity for Health Program – Mahefa Miaraka FY2017 Quarter 2 Report i USAID COMMUNITY CAPACITY FOR HEALTH PROGRAM - Mahefa Miaraka Cooperative Agreement No. AID-687-A-16-00001 FY2017 Quarter 2 Progress Report January 1 to March 31, 2017 Community Capacity for Health Program – Mahefa Miaraka FY2017 Quarter 2 Report ii USAID COMMUNITY CAPACITY FOR HEALTH PROGRAM - Mahefa Miaraka FY2017 Quarter 2 Progress Report Re-Submitted: June 5, 2017 (after USAID comments) Cooperative Agreement No. AID-687-A-16-00001 Submitted to: Dr. Jocelyne ANDRIAMIADANA, AOR USAID/Madagascar in Antananarivo, Madagascar Prepared by: JSI Research & Training Institute, Inc. USAID Community Capacity for Health Program – Mahefa Miaraka JSI Research & Training Institute, Inc. Résidence Lavalley Près Lot IIK 50H Mahatony Alarobia, Antananarivo (101) Tel: 20.22.425.78/ 79 Cover photo: Community Health Volunteer dresses a child after weighing in Maintirano District, Melaky Region. Photo: Chuanpit Chua-oon, JSI Research & Training Institute, Inc. DISCLAIMER: This document is made possible by the support of the American people through the United States Agency for International Development (USAID). The contents of this document are the responsibility of JSI Research & Training Institute, Inc. (JSI) and do not necessarily reflect the views of USAID or the United States Government. Community Capacity for Health Program – Mahefa Miaraka FY2017 Quarter 2 Report iii Table of Contents Executive Summary of Achievements in Q2 FY2017 ................................................................ 1 Introduction ................................................................................................................................... 2 Intervention Area 1 (IA 1):Community Engagement and Ownership of Health Services .... 3 Sub IA 1.1 Increasing Skills and Competencies of CHV in Priority Interventions ............................................. 3 Sub IA 1.2. Sustainability of the CHV Model....................................................................................................... 11 Sub IA 1.3 Strengthening of Community Structures, .............................................................................................. 11 Sub IA 1.4 Promoting Universal Health Care Access and Coverage .................................................................. 12 Intervention Area 2 (IA2): Behavior Change and Health Promotion .................................... 13 Sub IA 2.1. Community-Level Health Promotion and Sensitization to Increase Healthy Behavior and Uptake of Health Services and Products ................................................................................................................... 13 Sub IA 2.2 Capacity of Community Stakeholders in SBCC ................................................................. 14 Sub IA 2.3 Innovations to Promote Adolescent and Youth Health, with a Focus on Reaching Rural, Underserved, and Married Youth ................................................................................................................................ 16 Intervention Area 3: Health Service Planning, Management, and Governance ................... 17 Sub IA 3.0 Reinforcement of GOM Capacity............................................................................................................ 18 Sub IA 3.1. Introduction and Promotion of Non-Clinical Quality Improvement ............................................. 18 Sub IA 3.2. Pharmaceutical and Commodity Forecasting....................................................................................... 18 Sub IA 3.3. Health Data Quality, Management, and Use .................................................................... 19 Sub IA 3.4. Referral System Strengthening between CHVs and CSBs ................................................................ 20 Monitoring and Evaluation, Learning Management, and Cross-Cutting Issues .................... 21 Sub IA 4.1 Program Monitoring, Evaluation, and Performance System .............................................................. 21 Sub IA 4.2 Learning Management ................................................................................................................................. 22 Sub IA 4.3 Cross-Cutting Issues ................................................................................................................................... 22 Challenges and Proposed Solutions for Q2 FY2017 ................................................................ 23 Administrative and Financial Management .............................................................................. 23 Sub IA 0. 1 Operation (Administration, Finance, and Partnership) ..................................................................... 24 Sub IA 0. 2 Administration ............................................................................................................................................ 24 Sub IA 0.3 Financial Management ................................................................................................................................. 25 Annexes Annex 1. Activity Report Q2, FY2017 Annex 2. Project Performance Review, PPR (Q2, FY2017) Annex 3. Environment Monitoring and Mitigation Report, EMMR (Q2, FY2017) Annex 4. List of Communes in Mahefa Miaraka Program in Q2, FY2017 Annex 5. International Trips at the End of Q2 FY2017 Annex 6. Success Stories Annex 7. Participation in the Central-Level Working Groups and Meetings Annex 8. JSI Responses to USAID Comments with Additional Figures on Selected malaria Indicators Community Capacity for Health Program – Mahefa Miaraka FY2017 Quarter 2 Report iv List of Tables Table 1 – Comparison of cIMCI Services by CHVs between Q2 FY2016 (MAHEFA) and Q2 FY2017 (Mahefa Miaraka) ................................................................................................................................................................................... 6 Table 2 – Comparison of Selected Malaria Indicators between Q2 FY2016 (MAHEFA) and Q2 FY2017 (Mahefa Miaraka), by Region .............................................................................................................................................................. 6 Table 3 - Referral Cases from CHVs to CSBs, Hospitals, or Mobile Clinics in Q2, FY2017 ...................................... 7 Table 4 – Reasons for Non-Functionality and Plans to Revitalize the Mutuelle de Santé ........................................ 12 Table 5 – Current Situation of Emergency Transport Activities Started in the MAHEFA Program ....................... 13 Table 6 - Program Participation in the GOM Health Days and Campaign in Q2 FY2017 ......................................... 14 Table 7 - Mahefa Miaraka’s Cumulative Expenses as of March 31, 2017 ........................................................................ 25 List of Boxes Box 1 – A Child Being Weighed by CHVs, Maintirano District, Melaky Region ............................................................ 4 Box 2 – Joint Visit USAID and MOH Led by MOH Secretary General, Sofia Region ................................................ 11 Box 3 - TOT for members of the PNSC Structures on SBCC in Sofia Region ............................................................ 14 Box 4 - Supervision Visit by MOH Regional Trainer, Boeny Region ............................................................................... 18 Box 5 - Supervision Visit by CSB Head, Menabe Region .................................................................................................... 19 Box 6 – CHVs’ Response to Malaria Outbreaks in Melaky and Boeny Regions .......................................................... 20 Box 7 – Madagascar’s Booth at the 2017 Institutionalizing Community Health Conference, Johanesburg, South Africa ...................................................................................................................................................................................... 22 List of Figures Figure 1- Percentage of CHV who Received c-IMCI Training in Q2 FY2017, by Region (n=9,774) ..................... 4 Figure 2- Results for CU5 with MUAC Measurement in Q2, FY2017 (n=48,167) ................................................ 5 Figure 3- Cases of CU5 Treated for c-IMCI by CHVs in Q2 FY2017 ................................................................... 5 Figure 4- Regular Family Planning Users in the Program, by Age Group, Q2 FY2017 .......................................... 7 Figure 5- New Family Planning Users in the Program, by Age Group, Q2 FY2017 .............................................. 8 Figure 6- Couple Years of Protection by Family Planning Methods, Q2 FY2017 .................................................. 8 Figure 7- Stockout Reported by CHVs for Child Health Tracer Products, Q2 FY2017 ....................................... 9 Figure 8- Stockout Reported by CHVs for Family Planning Tracer Products, Q2 FY2017 ................................... 9 Figure 9- People Reached by Multiple Channels for Key Health Messages in Q2 FY2017 .................................. 15 Figure 10- Photos from High-Visibility Events in Q2 FY2017 .............................................................................. 17 Community Capacity for Health Program – Mahefa Miaraka FY2017 Quarter 2 Report v Acronyms and Abbreviations ACT Artemisinin-based Combination Therapy AIDS Acquired Immune Deficiency Syndrome ANC Antenatal Care ASOS Action